Nifty

:

24056.00

Sensex

:

77100.47

34.35 (0.14%)
109.25 (0.14%)

Login

Nifty
Sensex

:
:

24056.00
77100.47

34.35 (0.14%)
109.25 (0.14%)

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

72/99

BSE: 506820 | NSE: ASTRAZEN

Watchlist

NSE BSE

8391.00

25-Jun-2026

Open
High
Low
Previous Close

8499.5
8499.5
8352
8442.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1029
8667985
9849.5
7551.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

20,956.63
111.76
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

20,508.01
0.43%
24.01

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.78
16.10
19.61

EBITDA CAGR (%)

10 Years
5 Years
3 Years

31.50
13.39
8.99

PAT CAGR (%)

10 Years
5 Years
3 Years

36.22
4.40
5.24

P:E (Median)

8 Years
5 Years
3 Years

108.19
107.08
111.05

P:BV (Average)

8 Years
5 Years
3 Years

21.17
20.67
24.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

63.69
63.65
67.24

Earnings Forecasts:

(Updated: 23-06-2026)

Description 2026 2027 2028 2029
Adj EPS - - - -
P/E Ratio - - - -
Revenue - 1390 1680 -
EBITDA - 380 480 -
Net Income - 230 300 -
ROA - - - -
P/B Ratio - - - -
ROE - 16 17 -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 578.61 480.48 20.42% 611.57 440.29 38.90% 559.09 408.00 37.03% 526.31 387.52 35.81%
Expenses 517.70 394.11 31.36% 566.74 363.30 56.00% 483.91 355.46 36.14% 445.20 349.45 27.40%
EBITDA 60.91 86.37 -29.48% 44.83 76.99 -41.77% 75.18 52.54 43.09% 81.11 38.07 113.05%
EBIDTM 10.53% 17.98% 7.33% 17.49% 13.45% 12.88% 15.41% 9.82%
Other Income 5.95 16.15 -63.16% 5.13 7.98 -35.71% 6.17 8.15 -24.29% 11.24 8.35 34.61%
Interest 2.04 0.68 200.00% 1.06 0.33 221.21% 0.67 0.34 97.06% 0.72 0.11 554.55%
Depreciation 5.60 17.69 -68.34% 3.84 9.07 -57.66% 2.57 9.32 -72.42% 16.57 3.91 323.79%
PBT 58.14 78.47 -25.91% 46.54 42.02 10.76% 72.82 51.03 42.70% 74.70 -15.16 -
Tax 13.26 20.22 -34.42% 13.95 11.17 24.89% 18.60 12.60 47.62% 18.87 -3.37 -
PAT 44.88 58.25 -22.95% 32.59 30.85 5.64% 54.22 38.43 41.09% 55.83 -11.79 -
PATM 7.76% 12.12% 5.33% 7.01% 9.70% 9.42% 10.61% -3.04%
EPS 17.95 23.30 -22.96% 13.04 12.34 5.67% 21.69 15.37 41.12% 22.33 -4.72 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56 831.81 728.29 571.00 543.71 563.73 Net Sales Growth 32.59% 32.48% 29.17% 24.50% -0.98% -2.19% 14.21% 27.55% 5.02% -3.55% Cost Of Goods Sold 1,380.54 957.79 590.03 355.22 305.28 287.30 299.97 226.73 178.21 171.18 194.81 Gross Profit 895.04 758.50 705.50 647.75 500.32 526.26 531.84 501.56 392.79 372.53 368.93 GP Margin 39.33% 44.19% 54.46% 64.58% 62.11% 64.69% 63.94% 68.87% 68.79% 68.52% 65.44% Total Expenditure 2,013.55 1,462.32 1,111.08 837.85 719.42 678.09 711.11 656.99 524.71 506.77 547.31 Power & Fuel Cost - 5.30 4.87 5.54 8.10 7.37 7.72 8.27 8.30 7.68 7.43 % Of Sales - 0.31% 0.38% 0.55% 1.01% 0.91% 0.93% 1.14% 1.45% 1.41% 1.32% Employee Cost - 257.44 241.45 259.10 230.21 219.54 216.70 197.40 150.39 162.04 169.35 % Of Sales - 15.00% 18.64% 25.83% 28.58% 26.99% 26.05% 27.10% 26.34% 29.80% 30.04% Manufacturing Exp. - 48.57 89.46 76.04 57.12 49.32 40.81 49.58 50.67 36.40 25.82 % Of Sales - 2.83% 6.91% 7.58% 7.09% 6.06% 4.91% 6.81% 8.87% 6.69% 4.58% General & Admin Exp. - 75.41 66.30 56.66 40.04 40.69 65.54 74.09 46.49 55.04 59.10 % Of Sales - 4.39% 5.12% 5.65% 4.97% 5.00% 7.88% 10.17% 8.14% 10.12% 10.48% Selling & Distn. Exp. - 103.93 97.48 71.57 62.09 55.94 65.13 88.18 81.07 62.56 84.65 % Of Sales - 6.06% 7.52% 7.14% 7.71% 6.88% 7.83% 12.11% 14.20% 11.51% 15.02% Miscellaneous Exp. - 13.88 21.49 13.72 16.58 17.93 15.24 12.74 9.58 11.87 84.65 % Of Sales - 0.81% 1.66% 1.37% 2.06% 2.20% 1.83% 1.75% 1.68% 2.18% 1.09% EBITDA 262.03 253.97 184.45 165.12 86.18 135.47 120.70 71.30 46.29 36.94 16.42 EBITDA Margin 11.51% 14.80% 14.24% 16.46% 10.70% 16.65% 14.51% 9.79% 8.11% 6.79% 2.91% Other Income 28.49 40.63 34.80 26.10 14.76 12.84 12.99 16.29 12.25 14.39 6.77 Interest 4.49 1.46 1.20 0.63 0.95 1.09 1.14 0.00 0.00 0.00 0.00 Depreciation 28.58 39.99 14.94 16.26 16.95 20.13 18.58 14.92 14.74 15.83 17.43 PBT 252.20 253.15 203.11 174.33 83.04 127.09 113.97 72.67 43.80 35.50 5.76 Tax 64.68 40.62 58.03 34.81 21.44 33.79 41.76 18.22 17.89 15.45 0.50 Tax Rate 25.65% 25.98% 26.43% 25.96% 25.82% 26.59% 36.64% 25.07% 40.84% 43.52% 8.68% PAT 187.52 115.74 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 5.26 PAT before Minority Interest 187.52 115.74 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 5.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.24% 6.74% 12.47% 9.90% 7.65% 11.47% 8.68% 7.48% 4.54% 3.69% 0.93% PAT Growth 62.02% -28.34% 62.66% 61.19% -33.98% 29.21% 32.62% 110.15% 29.23% 281.18% EPS 75.01 46.30 64.60 39.72 24.64 37.32 28.88 21.78 10.36 8.02 2.10

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 770.35 711.92 588.69 511.39 456.17 364.44 300.80 246.93 222.87 156.01 Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Total Reserves 758.20 703.63 581.12 504.44 449.58 357.85 293.70 239.85 216.22 151.01 Non-Current Liabilities 159.13 97.83 68.99 73.63 44.60 44.13 22.75 109.73 88.68 38.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 162.24 116.30 85.97 84.91 50.50 49.47 46.11 142.28 128.90 37.70 Current Liabilities 908.15 467.15 484.40 392.30 373.43 367.10 267.60 218.67 202.05 234.05 Trade Payables 456.30 196.51 227.88 190.44 178.37 209.72 168.20 127.20 87.66 94.63 Other Current Liabilities 129.53 110.53 111.95 94.23 82.58 71.06 54.38 39.41 69.84 121.08 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 322.32 160.11 144.57 107.63 112.48 86.32 45.02 52.06 44.55 18.33 Total Liabilities 1,837.63 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60 429.02 Net Block 64.24 66.68 68.86 74.49 80.96 71.53 74.83 75.46 86.84 97.36 Gross Block 217.62 187.13 179.12 168.83 159.78 132.84 119.83 105.85 102.57 203.76 Accumulated Depreciation 153.38 120.45 110.26 94.34 78.82 61.31 45.00 30.39 15.73 106.40 Non Current Assets 290.13 234.16 206.14 212.00 185.51 193.49 177.81 242.69 250.34 161.95 Capital Work in Progress 0.00 0.27 1.33 2.20 4.02 24.24 6.90 3.57 4.81 6.31 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 222.24 167.21 135.95 135.31 100.52 97.71 95.83 163.39 158.27 57.68 Other Non Current Assets 3.65 0.00 0.00 0.00 0.01 0.01 0.25 0.27 0.42 0.61 Current Assets 1,547.50 1,042.74 935.94 765.32 688.69 582.18 413.34 332.64 263.26 267.07 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 548.50 227.88 190.21 140.22 159.80 165.15 118.10 113.15 57.71 76.73 Sundry Debtors 184.88 153.13 107.52 85.89 85.19 83.21 79.75 54.63 43.00 83.14 Cash & Bank 536.70 505.84 500.48 448.46 352.35 252.52 173.30 125.92 115.58 76.83 Other Current Assets 277.42 13.23 13.56 12.64 91.35 81.30 42.19 38.94 46.97 30.37 Short Term Loans & Adv. 261.22 142.66 124.17 78.11 81.51 71.18 33.26 30.87 26.74 20.22 Net Current Assets 639.35 575.59 451.54 373.02 315.26 215.08 145.74 113.97 61.21 33.03 Total Assets 1,837.63 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60 429.02

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 65.36 27.87 58.29 100.80 104.78 87.42 54.98 8.79 38.10 56.99 PBT 156.36 219.54 134.10 83.04 127.09 113.97 72.67 43.80 35.50 5.76 Adjustment 76.41 -7.07 -4.80 9.66 14.20 9.75 7.62 3.39 14.61 12.11 Changes in Working Capital -103.22 -128.17 -30.19 32.89 -3.95 -2.66 9.81 -34.25 -0.24 42.09 Cash after chg. in Working capital 129.55 84.30 99.11 125.59 137.34 121.06 90.10 12.94 49.87 59.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -64.19 -56.43 -40.82 -24.79 -32.56 -33.64 -35.12 -4.15 -11.77 -2.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 30.80 21.74 18.11 4.74 173.03 -170.80 4.28 -9.36 0.25 -3.61 Net Fixed Assets -30.22 -6.95 -9.42 -7.23 -6.72 -30.35 -17.31 -2.04 102.69 -6.42 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 61.02 28.69 27.53 11.97 179.75 -140.45 21.59 -7.32 -102.44 2.81 Cash from Financing Activity -65.59 -44.38 -24.48 -9.46 -8.97 -6.36 0.00 0.00 0.00 -0.51 Net Cash Inflow / Outflow 30.57 5.23 51.92 96.08 268.84 -89.74 59.26 -0.57 38.35 52.87 Opening Cash & Equivalents 505.57 500.34 448.42 352.34 83.50 173.24 113.98 114.55 76.20 23.33 Closing Cash & Equivalent 536.14 505.57 500.34 448.42 352.34 83.50 173.24 113.98 114.55 76.20

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 305.28 283.45 234.45 203.78 181.83 145.14 119.48 97.94 88.49 62.41 ROA 7.43% 13.35% 9.37% 6.65% 11.31% 10.57% 9.34% 4.76% 4.25% 1.25% ROE 15.73% 24.95% 18.13% 12.78% 22.83% 21.83% 20.03% 11.12% 10.63% 3.43% ROCE 21.29% 33.94% 24.49% 17.36% 31.24% 34.61% 26.53% 18.65% 18.74% 3.76% Fixed Asset Turnover 8.51 7.11 5.79 4.93 5.58 6.58 6.45 5.49 3.58 2.88 Receivable days 35.81 36.53 35.03 38.57 37.62 35.75 33.67 31.15 41.96 40.32 Inventory Days 82.25 58.60 59.85 67.64 72.59 62.15 57.95 54.51 44.72 52.15 Payable days 124.39 131.27 214.92 220.48 246.52 99.66 91.40 73.21 75.53 75.14 Cash Conversion Cycle -6.33 -36.14 -120.04 -114.26 -136.32 -1.76 0.22 12.45 11.15 17.33 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 108.10 183.95 213.86 88.41 117.60 100.97 0.00 0.00 0.00 0.00

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund(various schemes)

tejas bhalchandra trivedi

shivani tejas trivedi

bandhan - various schemes

icici prudential - various schemes

investor education and protection fund (iepf)

Annual Reports:

News Update:

AstraZeneca Pharma gets nod to import, market Acalabrutinib tablets 100 mg
13th Apr 2026, 10:08 AM

The company has received permission from the Central Drugs Standard Control Organisation
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback